血管內支架市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、產品、最終用途、地區和競爭格局分類，2021-2031年

全球血管內支架市場預計將從 2025 年的 132.2 億美元成長到 2031 年的 202.8 億美元，在此期間的複合年成長率為 7.39%。

這些裝置是可擴張的網狀管，用於重新開通狹窄或阻塞的動脈，對於恢復血流和確保血管通暢性至關重要。成長要素的關鍵因素包括全球人口快速老化和心血管疾病發病率的上升，這導致對冠狀動脈疾病等疾病的介入治療需求增加。根據歐洲心臟學會的數據，到2024年，心血管疾病每年在成員國造成的死亡人數將超過300萬，凸顯了對有效治療方案的迫切需求。

另一方面，它們也面臨來自嚴格的安全標準和產品核可法規結構的重大障礙。監管機構要求進行全面的臨床試驗，這延長了醫療設備進入商業市場前的研發週期，並增加了生產成本。此外，由於血栓症等不利事件導致的產品召回風險，將對品牌聲譽構成嚴重威脅，並可能延緩新興技術的市場推廣。

市場促進因素

全球心血管疾病發生率的上升趨勢是血管內支架產業的主要驅動力，因為需要進行更多血管成形術來治療動脈阻塞。隨著不健康飲食習慣和久坐生活方式的日益普遍，冠狀動脈疾病的發生率不斷上升，需要進行機械介入以維持足夠的血流。根據美國疾病管制與預防中心 (CDC) 於 2025 年 9 月發布的《關鍵統計快報》，心臟病仍將是 2024 年的首要死因，僅在美國就報告了 683,037 例死亡。這一持續存在的健康問題導致了對治療器械的穩定需求，而這一趨勢也反映在了該行業的表現中。Medtronic於 2025 年 6 月發布的《2025 會計年度年度報告》顯示，其心血管產品組合的淨銷售額為 125 億美元，凸顯了這些治療方法的全球重要性。

此外，支架材料和設計方面的技術創新也是成長要素，製造商不斷推出新一代產品，以加速患者康復並擴大適用患者範圍。藥物釋放型技術和生物可吸收支架等技術的進步，與傳統的裸金屬支架相比，顯著降低了血栓症和血管再阻塞的風險，使醫生能夠治療以往難以處理的周邊血管疾病和複雜病變。持續的研發投入正為主要企業帶來豐厚的回報。例如，雅培公司於2025年1月發布的「2024年第四季及全年財務業績」顯示，其醫療設備，以維持收入成長和市場發展勢頭。

市場挑戰

嚴格的安全標準和產品核可法律規範對全球血管內支架市場的擴張構成重大障礙。世界各地的監管機構都對品質保證和臨床試驗提出了嚴格的要求，製造商必須滿足這些要求才能將產品商業化。這些繁瑣的要求顯著延長了產品研發週期，增加了財務成本，常常迫使企業將資金從研發投入轉移出去。這種複雜的法規環境減緩了創新支架技術的應用，並限制了其在關鍵地區的使用。

根據歐洲醫療技術協會（MedTech Europe）2024年的數據，在新監管環境下，醫療設備認證的平均時間已延長至13-18個月，合規成本較以往指令增加了約100%。這些延誤和成本增加迫使製造商重新評估其市場策略，往往導致舊產品下架，以及在監管障礙較高的地區降低優先順序。因此，核准流程的停滯直接阻礙了市場成長，並限制了心血管疾病患者及時獲得先進治療方案的機會。

市場趨勢

在醫療保健成本效益需求和不斷變化的報銷政策的推動下，手術向門診手術中心 (ASC) 的轉移正在從根本上改變採購環境。醫療系統正在加速將經經皮冠狀動脈介入治療 (PCI) 從住院環境轉移到門診環境，以降低手術成本並緩解醫院容量問題。這項轉變的促進因素包括監管政策的變化，例如美國醫療保險和醫療補助服務中心 (CMS) 擴大了醫保覆蓋範圍，鼓勵醫療服務提供者在更經濟的環境下進行導管介入治療。因此，製造商正在調整其供應鏈，以滿足高運轉率門診中心獨特的物流和庫存需求。根據 HST Pathways 於 2025 年 3 月發布的《行業趨勢報告》，2024 年心臟病學手術佔 ASC 總手術時間利用率的 24%，這表明這些機構正在迅速轉向優先開展血管介入治療。

同時，將人工智慧 (AI) 應用於支架的選擇和尺寸確定，正在提高器械植入的精準度，並革新術前規劃。先進的演算法正與血管內成像工具（例如光同調斷層掃瞄(OCT)）相結合，以實現病變特徵和血管尺寸的自動化評估。這項技術進步解決了支架擴張不足和放置不當等關鍵挑戰，而這些正是血管再阻塞和器械失效的主要原因。透過機器學習分析複雜的影像數據，臨床醫生可以高精度地確定理想的著陸區和支架尺寸，從而改善長期治療效果。美國國立衛生研究院 (NIH) 於 2025 年 7 月發表的一篇題為《人工智慧在介入心臟病學中的應用》的綜述指出，深度學習演算法能夠以 94% 的準確率預測支架擴張不足，凸顯了這些工具在減少手術誤差方面的能力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血管內支架市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 類型（藥物釋放型支架、裸金屬支架、生物可吸收支架）
  • 產品類別（冠狀動脈支架、周邊血管支架）
  • 依用途（醫院/診所、門診手術中心、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美血管內支架市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲血管內支架市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區血管內支架市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲血管內支架市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美血管內支架市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球血管內支架市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Boston Scientific Corporation
• Medtronic plc.
• Terumo Medical Corporation
• Abbott Laboratories Inc.
• BIOTRONIK SE & Co. KG
• Stryker Corporation
• Microport Scientific Corporation
• Stentys SA
• HELLMAN & FRIEDMAN LLC
• B. Braun SE

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Intravascular Stents Market is projected to expand from a valuation of USD 13.22 Billion in 2025 to USD 20.28 Billion by 2031, registering a CAGR of 7.39% during this period. These devices, which are expandable mesh tubes utilized to reopen narrowed or blocked arteries, are essential for restoring blood flow and ensuring vessel patency. The primary growth factors include a rapidly aging global population and a growing incidence of cardiovascular diseases, which increase the necessity for interventional procedures to treat conditions like coronary artery disease. Data from the European Society of Cardiology indicates that in 2024, cardiovascular disease caused more than 3 million deaths annually across member nations, underscoring the urgent and continuing need for effective therapeutic solutions.

Conversely, the market encounters significant hurdles arising from strict regulatory frameworks regarding safety standards and product approvals. Regulatory bodies mandate exhaustive clinical testing, which prolongs development timelines and increases manufacturing costs before devices can enter the commercial market. Furthermore, the risk of product recalls triggered by adverse events, such as thrombosis, poses a serious threat to brand reputation and can delay the market adoption of emerging technologies.

Market Driver

The rising global prevalence of cardiovascular diseases acts as the main driver for the intravascular stents industry, necessitating a higher volume of angioplasty procedures to treat arterial obstructions. As poor dietary choices and sedentary lifestyles become more widespread, rates of coronary artery disease are increasing, requiring mechanical interventions to maintain adequate blood flow. According to the 'Vital Statistics Rapid Release' report published by the Centers for Disease Control and Prevention in September 2025, heart disease remained the primary cause of mortality in 2024, responsible for 683,037 deaths in the United States alone. This ongoing health burden ensures steady demand for therapeutic devices, a trend reflected in industry performance; Medtronic's 'Fiscal Year 2025 Annual Report' from June 2025 noted that their Cardiovascular Portfolio achieved $12.5 billion in net sales, highlighting the critical global need for these interventions.

Additionally, technological innovations in stent materials and design represent a significant growth driver, with manufacturers launching next-generation devices that enhance patient recovery and broaden the treatable population. Developments such as drug-eluting technologies and bioresorbable scaffolds have notably lowered the risks of thrombosis and restenosis compared to earlier bare-metal models, enabling physicians to address peripheral vascular conditions and complex lesions that were previously challenging to treat. Continuous R&D investment is generating substantial returns for major companies; for example, Abbott's 'Fourth-Quarter and Full-Year 2024 Results' from January 2025 reported a 13.7% growth in their Medical Devices segment, fueled partly by a surge exceeding 20% in Structural Heart revenue involving advanced scaffold technologies. This product evolution encourages healthcare facilities to upgrade their supplies, thereby maintaining revenue growth and market momentum.

Market Challenge

The strict regulatory frameworks that govern safety standards and product approvals constitute a major obstacle to the expansion of the Global Intravascular Stents Market. Worldwide regulatory bodies impose demanding quality assurance and clinical testing mandates that manufacturers must fulfill prior to commercializing a device. These extensive requirements significantly prolong the product development lifecycle and elevate financial costs, frequently forcing companies to divert funds away from research and development initiatives. This complicated regulatory environment slows the introduction of innovative stent technologies and limits their availability in critical geographic regions.

Data from MedTech Europe in 2024 indicates that under the new regulatory landscape, the average timeframe for medical device certification has increased to between 13 and 18 months, while compliance costs have risen by roughly 100% compared to earlier directives. These delays and increased expenses compel manufacturers to reassess their market strategies, often resulting in the withdrawal of legacy products or the deprioritization of regions with high regulatory barriers. Consequently, the sluggish approval process directly impedes market growth and restricts the timely accessibility of advanced therapeutic options for patients suffering from cardiovascular conditions.

Market Trends

The migration of procedures toward Ambulatory Surgical Centers (ASCs) is fundamentally reshaping the procurement landscape, influenced by the demand for cost-effective healthcare and evolving reimbursement policies. Healthcare systems are increasingly moving percutaneous coronary interventions (PCIs) from inpatient hospital settings to outpatient facilities to reduce procedural costs and manage hospital capacity issues. This transition is bolstered by regulatory changes, such as the broadening of CMS covered procedure lists, which encourage providers to conduct catheter-based interventions in these more economical settings; consequently, manufacturers are adjusting their supply chains to meet the specific logistical and inventory requirements of high-volume outpatient centers. According to the 'State of the Industry Report' by HST Pathways in March 2025, cardiology represented 24% of total ASC block time utilization in 2024, indicating a rapid shift toward prioritizing vascular interventions in these facilities.

Concurrently, the integration of artificial intelligence into stent selection and sizing is transforming pre-procedural planning by improving device deployment precision. Advanced algorithms are being combined with intravascular imaging tools, like Optical Coherence Tomography (OCT), to automate the assessment of lesion characteristics and vessel dimensions. This technological advancement tackles critical issues such as stent underexpansion and malapposition, which are primary causes of restenosis and device failure. By utilizing machine learning to analyze complex imaging data, clinicians can identify the ideal landing zone and stent size with superior accuracy, enhancing long-term outcomes; a review titled 'Harnessing Artificial Intelligence in Interventional Cardiology' by the National Institutes of Health in July 2025 noted that deep learning algorithms achieved 94% accuracy in predicting incomplete stent expansion, highlighting the capacity of these tools to reduce procedural errors.

Key Market Players

• Boston Scientific Corporation
• Medtronic plc.
• Terumo Medical Corporation
• Abbott Laboratories Inc.
• BIOTRONIK SE & Co. KG
• Stryker Corporation
• Microport Scientific Corporation
• Stentys S.A.
• HELLMAN & FRIEDMAN LLC
• B. Braun SE

Report Scope

In this report, the Global Intravascular Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravascular Stents Market, By Type

• Drug Eluting Stents
• Bare Metal Stents
• Bioabsorbable Stents

Intravascular Stents Market, By Product

• Coronary Stents
• Peripheral Stents

Intravascular Stents Market, By End-Use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Intravascular Stents Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravascular Stents Market.

Available Customizations:

Global Intravascular Stents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravascular Stents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents)
  • 5.2.2. By Product (Coronary Stents, Peripheral Stents)
  • 5.2.3. By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Intravascular Stents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intravascular Stents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Intravascular Stents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Intravascular Stents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End-Use

7. Europe Intravascular Stents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Intravascular Stents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Intravascular Stents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Intravascular Stents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Intravascular Stents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Intravascular Stents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Intravascular Stents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Intravascular Stents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Intravascular Stents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Intravascular Stents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Intravascular Stents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Intravascular Stents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Intravascular Stents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Intravascular Stents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Intravascular Stents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Intravascular Stents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End-Use

10. South America Intravascular Stents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Intravascular Stents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Intravascular Stents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Intravascular Stents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Intravascular Stents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boston Scientific Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic plc.
• 15.3. Terumo Medical Corporation
• 15.4. Abbott Laboratories Inc.
• 15.5. BIOTRONIK SE & Co. KG
• 15.6. Stryker Corporation
• 15.7. Microport Scientific Corporation
• 15.8. Stentys S.A.
• 15.9. HELLMAN & FRIEDMAN LLC
• 15.10. B. Braun SE

16. Strategic Recommendations

17. About Us & Disclaimer